Shenzhen Shanhai Innovation Technology Co., Ltd. secured nearly 100 million RMB in Series C financing led by Yuan Sheng Venture Capital to expand its operations in supramolecular materials and AI research, signaling strong confidence in its innovative capabilities.
Target Information
On April 16, Shenzhen Shanhai Innovation Technology Co., Ltd. (hereafter referred to as "Shanhai Innovation"), a member company of Chuangweiye, announced the completion of a nearly 100 million RMB Series C financing round, led by Yuan Sheng Venture Capital.
This funding will significantly enhance the company's expansion in the field of supramolecular new materials. The capital will primarily be allocated to upgrading the AI research and development platform for supramolecular new materials and facilitating the industrial application of these materials across diverse sectors, including health foods, pharmaceuticals, agriculture, and environmental protection. The company will also actively explore new energy operations, encompassing the development of safe electrolytes, recycling of used batteries, and recovery of silver powder from photovoltaic silicon wafers to drive technological accessibility and industry innovation.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
Shanhai Innovation, founded in 2017 by Professor Zhang Jiaheng, a doctoral supervisor at Harbin Institute of Technology (Shenzhen), is the first company to systematically apply supramolecular technology in both health and industrial sectors on a global scale. Its busi
Similar Deals
元生创投
invested in
深圳杉海创新技术有限公司
in 2023
in a Other deal
Disclosed details
Transaction Size: $14M